Kestra Advisory Services’s Lipocine LPCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-16,703
| Closed | -$49.8K | – | 2309 |
|
|
2023
Q3 | $49.8K | Hold |
16,703
| – | – | ﹤0.01% | 2053 |
|
|
2023
Q2 | $84.2K | Buy |
16,703
+2
| +0% | +$10 | ﹤0.01% | 2015 |
|
|
2023
Q1 | $90.3K | Hold |
16,701
| – | – | ﹤0.01% | 1964 |
|
|
2022
Q4 | $113K | Buy |
16,701
+448
| +3% | +$3.03K | ﹤0.01% | 2128 |
|
|
2022
Q3 | $124K | Buy |
16,253
+88
| +0.5% | +$671 | ﹤0.01% | 1953 |
|
|
2022
Q2 | $220K | Sell |
16,165
-1,911
| -11% | -$26K | ﹤0.01% | 1844 |
|
|
2022
Q1 | $421K | Buy |
18,076
+3,941
| +28% | +$91.8K | ﹤0.01% | 1388 |
|
|
2021
Q4 | $238K | Sell |
14,135
-537
| -4% | -$9.04K | ﹤0.01% | 1767 |
|
|
2021
Q3 | $272K | Buy |
14,672
+10,554
| +256% | +$196K | ﹤0.01% | 1751 |
|
|
2021
Q2 | $98K | Buy |
+4,118
| New | +$98K | ﹤0.01% | 1953 |
|
|
2021
Q1 | – | Sell |
-20,360
| Closed | -$453K | – | 1963 |
|
|
2020
Q4 | $453K | Buy |
+20,360
| New | +$453K | 0.01% | 1256 |
|